Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin
The erythrocytes in sickle cell disease have long been known to show decreased oxygen
affinity compared with those from healthy volunteers. 1–4 This property is measured as an …
affinity compared with those from healthy volunteers. 1–4 This property is measured as an …
Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin.
MK Safo, GJ Kato - Hematology/oncology Clinics of North America, 2014 - europepmc.org
The fundamental pathophysiology of sickle cell disease involves the polymerization of sickle
hemoglobin in its T-state which develops under low oxygen saturation. One therapeutic …
hemoglobin in its T-state which develops under low oxygen saturation. One therapeutic …
[HTML][HTML] Therapeutic Strategies to Alter Oxygen Affinity of Sickle Hemoglobin
MK Safo, GJ Kato - Hematology/oncology clinics of North America, 2014 - ncbi.nlm.nih.gov
The fundamental pathophysiology of sickle cell disease involves the polymerization of sickle
hemoglobin in its T-state which develops under low oxygen saturation. One therapeutic …
hemoglobin in its T-state which develops under low oxygen saturation. One therapeutic …
Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin
MK Safo, GJ Kato - Hematology/Oncology Clinics of North …, 2014 - jhu.pure.elsevier.com
The pathophysiology of sickle cell disease involves the polymerization of sickle hemoglobin
in its T state, which develops under low oxygen saturation. One therapeutic strategy is to …
in its T state, which develops under low oxygen saturation. One therapeutic strategy is to …
Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin
MK Safo, GJ Kato - Hematology/oncology clinics of North …, 2014 - pubmed.ncbi.nlm.nih.gov
The pathophysiology of sickle cell disease involves the polymerization of sickle hemoglobin
in its T state, which develops under low oxygen saturation. One therapeutic strategy is to …
in its T state, which develops under low oxygen saturation. One therapeutic strategy is to …
Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin
MK Safo, GJ Kato - Hematology/Oncology Clinics of North …, 2014 - pure.johnshopkins.edu
The pathophysiology of sickle cell disease involves the polymerization of sickle hemoglobin
in its T state, which develops under low oxygen saturation. One therapeutic strategy is to …
in its T state, which develops under low oxygen saturation. One therapeutic strategy is to …
[PDF][PDF] Therapeutic Strategies to Alter Oxygen Affinity of Sickle Hemoglobin
HOCN Am - Hematol Oncol Clin North Am, 2014 - researchgate.net
The fundamental pathophysiology of sickle cell disease involves the polymerization of sickle
hemoglobin in its T-state which develops under low oxygen saturation. One therapeutic …
hemoglobin in its T-state which develops under low oxygen saturation. One therapeutic …
Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin.
MK Safo, GJ Kato - Hematology/oncology Clinics of North America, 2014 - europepmc.org
The fundamental pathophysiology of sickle cell disease involves the polymerization of sickle
hemoglobin in its T-state which develops under low oxygen saturation. One therapeutic …
hemoglobin in its T-state which develops under low oxygen saturation. One therapeutic …